Article references (27 references )

  1. WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. WHO press; Geneva. 2015. Google Scholar

  2. WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection. WHO press; Geneva. 2014. Google Scholar

  3. World Health Organisation. HIV/AIDS global and regional statistics report 201 fact sheet. Geneva, 2014. Google Scholar

  4. Idrees MK, Batool S, Ahmed E. Hepatitis B virus among maintainence haemodialysis patients: a report from Karachi, Pakistan. The Journal of the Pakistan Medical Association. 2011; 61(12): 1210-1214. PubMed | Google Scholar

  5. Hasanjani Roushan MR, Farokhtabar S, Bayani M, Siadati S. Epidemiological aspects of hepatitis B and C and human immunodeficiency viruses among hemodialysis patients in Mazandaran Province, Iran. Nephro-urology monthly. 2016; 8(3): e37878. PubMed | Google Scholar

  6. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney international. 2003; 63(6): 2222-2229. PubMed | Google Scholar

  7. Bernieh B. Viral hepatitis in hemodialysis: an update. Journal of translational internal medicine. 2015; 3(3): 93-105. PubMed | Google Scholar

  8. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, Jha V, Wang T, Kawaguchi Y, Qian J. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-pacific countries: analysis of registry data: nephrology, dialysis, transplantation. Official publication of the European dialysis and transplant association, European renal association. 2009; 24(5): 1598-1603. PubMed | Google Scholar

  9. Fabrizi F. Hepatitis C virus infection and dialysis: 2012 update. ISRN nephrology. 2013; 159760. Google Scholar

  10. World Population Review. Cameroon Population 2017. Accessed 20th May 2017.

  11. Halle MP LH, Temfack E, Tchamago V, Kaze FK, Ashuntantang G, Biwole MS. Prevalence of hepatitis B surface antigen and anti-hiv antibodies among patients on maintenance haemodialysis in douala, cameroon. Health sciences and disease. 2013; 14(3): 1-5. Google Scholar

  12. Halle MP, Choukem SP, Kaze FF, Ashuntantang G, Tchamago V, Mboue-Djieka Y, Temfack E, Luma HN. Hepatitis B, Hepatitis C and Human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon. Iranian journal of kidney diseases. 2016; 10(5): 304-309. PubMed | Google Scholar

  13. Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I. Infections in hemodialysis: a concise review, Part II: blood transmitted viral infections. Hippokratia. 2011; 15(2): 120-126. PubMed | Google Scholar

  14. Kidney Disease: improving global outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney international Supplement. 2008; 73(109): S1-99. Google Scholar

  15. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC infectious diseases. 2012; 12: 265. PubMed | Google Scholar

  16. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012; 84(1): 52-55. PubMed | Google Scholar

  17. Al Zabadi H, Rahal H, Fuqaha R. Hepatitis B and C prevalence among hemodialysis patients in the West Bank hospitals, Palestine. BMC infectious diseases. 2016; 16: 41. PubMed | Google Scholar

  18. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab journal of nephrology and transplantation. 2011; 4(1): 35-47. PubMed | Google Scholar

  19. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. American journal of infection control. 2004; 32(8): 493-495. PubMed | Google Scholar

  20. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman province, South-East Iran. Hepatitis monthly.2012; 12(5): 339-343. PubMed | Google Scholar

  21. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss medical weekly. 2003; 133(45-46): 611-618. PubMed | Google Scholar

  22. Ocak S, Duran N, Kaya H, Emir I. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. International journal of clinical practice. 2006; 60(6): 670-674. PubMed | Google Scholar

  23. Unaids. HIV and AIDS estimates. Country progress reports. 2014-2015. Google Scholar

  24. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. Nephrologie & therapeutique. 2005; 1(5): 274-284. PubMed | Google Scholar

  25. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. Journal of the American Society of Nephrology. 2007; 18(11): 2968-2974. PubMed | Google Scholar

  26. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. The Journal of infectious diseases. 2008; 197(11): 1548-1557. PubMed | Google Scholar

  27. D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Seminars in nephrology. 1998; 18(4): 406-421. PubMed | Google Scholar